Css LLC Relmada Therapeutics, Inc. Transaction History

Css LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$18.3 - $37.02 $340,654 - $689,127	-18,615 Reduced 89.2%	2,253 $83,000
Q2 2022 Aug 15, 2022	SELL	$16.5 - $30.34 $25,789 - $47,421	-1,563 Reduced 6.97%	20,868 $396,000
Q1 2022 May 16, 2022	BUY	$16.72 - $26.99 $43,003 - $69,418	2,572 Added 12.95%	22,431 $605,000
Q4 2021 Feb 14, 2022	BUY	$16.93 - $26.82 $25,395 - $40,230	1,500 Added 8.17%	19,859 $447,000
Q3 2021 Nov 15, 2021	BUY	$21.86 - $34.77 $401,327 - $638,342	18,359 New	18,359 $481,000

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.9M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.